Sopharma AD Cash Flow-to-Debt Ratio
Sopharma AD cash flow-to-debt ratio. Sopharma AD (SPH) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2025, meaning its operating cash flow of zł-17.24 Million could theoretically repay 0% of its total liabilities (zł1.05 Billion) in one year. Check SPH capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sopharma AD (2011–2024)
Cash flow-to-debt ratio of Sopharma AD from 2011 to 2024. Historical debt coverage capacity for Sopharma AD across 14 annual periods. Check Sopharma AD (SPH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Sopharma AD Cash Flow-to-Debt Ratio by Year (2011–2024)
Sopharma AD cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Sopharma AD. For the full cash flow conversion analysis, see cash efficiency ratio of Sopharma AD.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | zł76.73 Million | zł953.18 Million | ▲ +35.9% |
| 2023 | 0.06x | zł45.03 Million | zł760.54 Million | ▼ -74.5% |
| 2022 | 0.23x | zł124.62 Million | zł537.67 Million | ▲ +266.6% |
| 2021 | -0.14x | zł-75.96 Million | zł546.11 Million | ▲ +47.6% |
| 2020 | -0.27x | zł-179.41 Million | zł675.52 Million | ▼ -24.0% |
| 2019 | -0.21x | zł-128.44 Million | zł599.50 Million | ▼ -479.5% |
| 2018 | 0.06x | zł28.34 Million | zł502.07 Million | ▼ -32.6% |
| 2017 | 0.08x | zł40.00 Million | zł477.62 Million | ▼ -39.1% |
| 2016 | 0.14x | zł50.64 Million | zł368.00 Million | ▲ +144.0% |
| 2015 | 0.06x | zł21.31 Million | zł377.99 Million | ▲ +7.8% |
| 2014 | 0.05x | zł20.18 Million | zł385.73 Million | ▼ -33.8% |
| 2013 | 0.08x | zł29.25 Million | zł370.01 Million | ▼ -20.5% |
| 2012 | 0.10x | zł35.20 Million | zł354.06 Million | ▼ -19.6% |
| 2011 | 0.12x | zł38.40 Million | zł310.78 Million | — |